Sponsored by:

Pulmonary

Scott Williams
Apr 2, 2002
 

Simplified Practical Chart of Pulmonary
Vascular Segmental Anatomy.

Cote rendition of a practical pulmonary segmental chart to be used for the interpretation of V/Q lung scans.

Lsegs

[Table of Content]

Latest in Nuclear Medicine
Fda Button 400
C-Ray Therapeutics wins FDA active status for Cu-64 drug master file
April 28, 2026
Molecular Imaging News Platform: trends, insights, professional views.
Sponsored
Molecular Imaging News Platform: trends, insights, professional views.
April 14, 2026
Isotopes1
Ionetix raises $30M to scale radioisotope production
April 21, 2026
A Ibrain
Telix doses first patient in glioblastoma trial
April 15, 2026
Related Stories
Whole Body
Nuclear Medicine
Prostascint (111In-Capromab Pendetide) (CYT-356)
Primary Ct
Nuclear Medicine
PET > PET tumor imaging > Breast Cancer
Case1 Mr Cor
Nuclear Medicine
PET > PET tumor imaging > CNS
Molecular Imaging News Platform: trends, insights, professional views.
Sponsor Content
Molecular Imaging News Platform: trends, insights, professional views.
More in Nuclear Medicine
C-Ray Therapeutics wins FDA active status for Cu-64 drug master file
By AuntMinnie.com staff writers
C-Ray Therapeutics has received active status from the FDA for its Type II Drug Master File for Cu-64 chloride for radiolabeling.
April 28, 2026
Fda Button 400
TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies
By AuntMinnie.com staff writers
TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.
April 22, 2026
A Rk Nx1 Fop15 Je H Jffj8rq D13
Ionetix raises $30M to scale radioisotope production
By AuntMinnie.com staff writers
The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.
April 21, 2026
Isotopes1
Telix doses first patient in glioblastoma trial
By AuntMinnie.com staff writers
The patient was dosed at Austin Health in Melbourne, Australia.
April 15, 2026
A Ibrain
Shine receives $263M conditional loan for Mo-99 isotope facility
By AuntMinnie.com staff writers
Shine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.
April 9, 2026
Chrysalis, Shine’s large-scale irradiation facility, will complement the existing supply chain with the goal of ensuring a sustainable and reliable source of isotopes, including Mo-99.
First patients treated in RYZ401 radiopharmaceutical trial
By AuntMinnie.com staff writers
RYZ401 is an investigational actinium-225 (AC-225)-based radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors.
April 8, 2026
Atom Molecule
Consortium launches 5-year plan to improve theranostics outcomes
By Will Morton
The project aims to pave the way for personalized radiopharmaceutical therapy.
April 6, 2026
Isotopes1
SpectronRx raises $85M to expand radiopharmaceutical production
By AuntMinnie.com staff writers
The funding will support infrastructure investment at the company's Grissom Aeroplex campus in Indiana.
April 2, 2026
Cash
Cardinal Health expands Ac-225 production
By AuntMinnie.com staff writers
Since launching routine Ac-225 production at scale in late 2024, the company said it has quadrupled its weekly output.
April 1, 2026
Isotopes1
Radiopharmaceutical Therapy Tracker
With so many targeted diagnostic and therapeutic radiopharmaceuticals in development for cancer care, AuntMinnie's new pipeline update tool can help keep track.
March 30, 2026
Rt Tracker
Varian nets FDA clearance for TrueBeam in osteoarthritis treatment
By AuntMinnie.com staff writers
Varian has received U.S. FDA clearance for the use of low-dose radiation therapy with its Varian TrueBeam radiotherapy systems.
March 19, 2026
TrueBeam radiotherapy system
TerraPower Isotopes to build Ac-225 facility in Philadelphia
By AuntMinnie.com staff writers
The new site will increase the company's actinium-225 (Ac-225) production capacity 20-fold.
March 18, 2026
Isotopes1
Page 1 of 442
Next Page